{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:58:12Z","timestamp":1769047092811,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T00:00:00Z","timestamp":1346198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.2119\/molmed.2012.00271","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T16:06:50Z","timestamp":1357574810000},"page":"1261-1268","source":"Crossref","is-referenced-by-count":58,"title":["Insulinlike Growth Factor (IGF)-1 Administration Ameliorates Disease Manifestations in a Mouse Model of Spinal and Bulbar Muscular Atrophy"],"prefix":"10.1186","volume":"18","author":[{"given":"Carlo","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-lian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George G.","family":"Harmison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pennuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Fischbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,29]]},"reference":[{"key":"18091261_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR Spada La","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:77\u20139.","journal-title":"Nature"},{"key":"18091261_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng1292-301","volume":"2","author":"AR Spada La","year":"1992","unstructured":"La Spada AR, et al. (1992) Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 2:301\u20134.","journal-title":"Nat. Genet."},{"key":"18091261_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H Adachi","year":"2005","unstructured":"Adachi H, et al. (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain. 128:659\u201370.","journal-title":"Brain"},{"key":"18091261_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy WR, Alter M, Sung JH. (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology. 18:671\u201380.","journal-title":"Neurology"},{"key":"18091261_CR5","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awp258","volume":"132","author":"LE Rhodes","year":"2009","unstructured":"Rhodes LE, et al. (2009) Clinical features of spinal and bulbar muscular atrophy. Brain. 132:3242\u201351.","journal-title":"Brain"},{"key":"18091261_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pneurobio.2011.10.003","volume":"97","author":"F Sambataro","year":"2011","unstructured":"Sambataro F, Pennuto M. (2011) Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases. Prog. Neurobiol. 97:152\u201372.","journal-title":"Prog. Neurobiol."},{"key":"18091261_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000335311","volume":"9","author":"K Bricceno","year":"2012","unstructured":"Bricceno K, Fischbeck KH, Burnett BG. (2012) Neurogenic and myogenic contributions to hereditary motor neuron disease. Neurodegener. Dis. 9:199\u2013209.","journal-title":"Neurodegener. Dis."},{"key":"18091261_CR8","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1212\/WNL.42.11.2181","volume":"42","author":"CL Warner","year":"1992","unstructured":"Warner CL, et al. (1992) X-linked spinomuscular atrophy: a kindred with associated abnormal androgen receptor binding. Neurology. 42:2181\u20132184.","journal-title":"Neurology"},{"key":"18091261_CR9","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/archneur.61.8.1324","volume":"61","author":"M Sinnreich","year":"2004","unstructured":"Sinnreich M, Klein CJ. (2004) Bulbospinal muscular atrophy: Kennedy\u2019s disease. Arch. Neurol. 61:1324\u20136.","journal-title":"Arch. Neurol."},{"key":"18091261_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30:575\u2013621.","journal-title":"Annu. Rev. Neurosci."},{"key":"18091261_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno M, et al. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal bulbar muscular atrophy. Neuron. 35:843\u201354.","journal-title":"Neuron"},{"key":"18091261_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K Takeyama","year":"2002","unstructured":"Takeyama K, et al. (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 35:855\u201364.","journal-title":"Neuron"},{"key":"18091261_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno M, et al. (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9:768\u201373.","journal-title":"Nat. Med."},{"key":"18091261_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, et al. (2010) Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group: efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicenter, randomized, double-blind, placebo-controlled trial. Lancet Neurol. 9:875\u201384.","journal-title":"Lancet Neurol."},{"key":"18091261_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes LE, et al. (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomized placebo-controlled trial. Lancet Neurol. 10:140\u20137.","journal-title":"Lancet Neurol."},{"key":"18091261_CR16","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES, et al. (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24:4778\u201386.","journal-title":"J. Neurosci."},{"key":"18091261_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","volume":"41","author":"BL Sopher","year":"2004","unstructured":"Sopher BL, et al. (2004) Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron. 41:687\u201399.","journal-title":"Neuron"},{"key":"18091261_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0896-6273(03)00258-7","volume":"38","author":"ES Emamian","year":"2003","unstructured":"Emamian ES, et al. (2003) Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron. 38:375\u201387.","journal-title":"Neuron"},{"key":"18091261_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0092-8674(03)00349-0","volume":"113","author":"HK Chen","year":"2003","unstructured":"Chen HK, et al. (2003) Interaction of Akt-phosphorylated ataxin-1 with 14\u20133\u20133 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 113:457\u201368.","journal-title":"Cell"},{"key":"18091261_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, et al. (2009) Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron. 64:828\u201340.","journal-title":"Neuron"},{"key":"18091261_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","volume":"16","author":"I Palazzolo","year":"2007","unstructured":"Palazzolo I, et al. (2007) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum. Mol. Genet. 16:1593\u2013603.","journal-title":"Hum. Mol. Genet."},{"key":"18091261_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I, et al. (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 63:316\u201328.","journal-title":"Neuron"},{"key":"18091261_CR23","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Committee for the Update of the Guide for the Careuse of Laboratory Animals, Institute for Laboratory Animal Research, Division on EarthLife Studies, National Research Council of the National Academies","year":"2011","unstructured":"Committee for the Update of the Guide for the Care and use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies. (2011) Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press. [cited 2012 Oct 29]. Available from: https:\/\/doi.org\/oacu.od.nih.gov\/regs\/","edition":"8"},{"key":"18091261_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/0470119055","volume-title":"What\u2019s Wrong with My Mouse?","author":"JN Crawley","year":"2007","unstructured":"Crawley JN. (2007) What\u2019s Wrong with My Mouse? Hoboken, NJ: John Wiley & Sons, p. 72\u201373."},{"key":"18091261_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neuron.2007.12.021","volume":"57","author":"M Pennuto","year":"2008","unstructured":"Pennuto M, et al. (2008) Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron. 57:393\u2013405.","journal-title":"Neuron"},{"key":"18091261_CR26","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1210\/jc.2005-1017","volume":"91","author":"C Camacho-H\u00fcbner","year":"2006","unstructured":"Camacho-H\u00fcbner C, et al. (2006) Pharmacokinetic studies of recombinant human insulin-like growth factor 1 (rhIGF-1)\/rhIGF-binding protine-3 complex administered to patients with growth hormone insensitivity syndrome. J. Clin. Endocrinol. Metab. 91:1246\u201353.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18091261_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/00005373-199911000-00015","volume":"47","author":"MA Debroy","year":"1999","unstructured":"Debroy MA, et al. (1999) Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J. Trauma. 47:904\u201310.","journal-title":"J. Trauma."},{"key":"18091261_CR28","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1210\/jc.2006-2699","volume":"92","author":"DR Clemmons","year":"2007","unstructured":"Clemmons DR, Sleevi M, Allan G, Sommer A. (2007) Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes. J. Clin. Endocrinol. Metab. 92:2652\u20138.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"18091261_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","volume":"127","author":"E Jacinto","year":"2006","unstructured":"Jacinto E, et al. (2006) SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 127:125\u201337.","journal-title":"Cell"},{"key":"18091261_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li M, et al. (1998) Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44:249\u201354.","journal-title":"Ann. Neurol."},{"key":"18091261_CR31","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1074\/jbc.M609972200","volume":"282","author":"M Li","year":"2007","unstructured":"Li M, Chevalier-Larsen ES, Merry DE, Diamond MI. (2007) Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J. Biol. Chem. 282:3157\u201364.","journal-title":"J. Biol. Chem."},{"key":"18091261_CR32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neurobiolaging.2006.05.015","volume":"28","author":"P Rusmini","year":"2007","unstructured":"Rusmini P, et al. (2007) Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol. Aging. 28:1099\u2013111.","journal-title":"Neurobiol. Aging"},{"key":"18091261_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.yfrne.2011.06.003","volume":"32","author":"S Parodi","year":"2011","unstructured":"Parodi S, Pennuto M. (2011) Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Front Neuroendocrinol. 32:416\u201325.","journal-title":"Front Neuroendocrinol"},{"key":"18091261_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky NB, et al. (2010) Native function of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 67:936\u201352.","journal-title":"Neuron"},{"key":"18091261_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygcen.2010.04.009","volume":"167","author":"C Duan","year":"2010","unstructured":"Duan C, Ren H, Gao S. (2010) Insulin-like growth factors (IGFs), IGF-receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen. Comp. Endocrinol. 167:344\u201351.","journal-title":"Gen. Comp. Endocrinol."},{"key":"18091261_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri M, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:399\u2013412.","journal-title":"Cell"},{"key":"18091261_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1083\/jcb.110.4.1307","volume":"110","author":"P Caroni","year":"1990","unstructured":"Caroni P, Grandes P. (1990) Nerve sprouting in innervated adult skeletal muscle induced to exposure to elevated levels of insulin-like growth factors. J. Cell. Biol. 110:1307\u201317.","journal-title":"J. Cell. Biol."},{"key":"18091261_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/neu.480250702","volume":"25","author":"L Li","year":"1994","unstructured":"Li L, Oppenheim RW, Lei M, Houenou LJ. (1994) Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J. Neurobiol. 25:759\u201366.","journal-title":"J. Neurobiol."},{"key":"18091261_CR39","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1097\/00001756-200007140-00035","volume":"11","author":"Q Yuan","year":"2000","unstructured":"Yuan Q, et al. (2000) Effects of neurotrophic factors on motoneuron survival following axonal injury in newborn rats. Neuroreport. 11:2237\u201341.","journal-title":"Neuroreport"},{"key":"18091261_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1471-4159.2002.00830.x","volume":"81","author":"A Gorio","year":"2002","unstructured":"Gorio A, Lesma E, Madaschi L, Di Giulio AM. (2002) Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study. J. Neurochem. 81:194\u2013202.","journal-title":"J. Neurochem."},{"key":"18091261_CR41","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","volume":"49","author":"EC Lai","year":"1997","unstructured":"Lai EC, et al. (1997) Effect of recombinant human insulin-like growth factor-I on progression of ALS: a placebo-controlled study: the North America ALS\/IGF-I Study Group. Neurology. 49:1621\u201330.","journal-title":"Neurology"},{"key":"18091261_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1212\/WNL.51.2.583","volume":"51","author":"GD Borasio","year":"1998","unstructured":"Borasio GD, et al. (1998) A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group. Neurology. 51:583\u20136.","journal-title":"Neurology"},{"key":"18091261_CR43","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","volume":"71","author":"EJ Sorenson","year":"2008","unstructured":"Sorenson EJ, et al. (2008) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 71:1770\u20135.","journal-title":"Neurology"},{"key":"18091261_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","volume":"264","author":"G Sorar\u00f9","year":"2008","unstructured":"Sorar\u00f9 G, et al. (2008) Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264:100\u20135.","journal-title":"J. Neurol. Sci."},{"key":"18091261_CR45","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI28773.","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu Z, et al. (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 116:2663\u201372.","journal-title":"J. Clin. Invest."},{"key":"18091261_CR46","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1073\/pnas.0705501104","volume":"104","author":"DA Monks","year":"2007","unstructured":"Monks DA, et al. (2007) Overexpression of wildtype androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. U. S. A. 104:18259\u201364.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"18091261_CR47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0896-6273(92)90213-W","volume":"8","author":"PS DiStefano","year":"1992","unstructured":"DiStefano PS, et al. (1992) The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8:983\u201393.","journal-title":"Neuron"},{"key":"18091261_CR48","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1126\/science.7770776","volume":"268","author":"H Funakoshi","year":"1995","unstructured":"Funakoshi H, et al. (1995) Muscle-derived neu-rotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science. 268:1495\u20139.","journal-title":"Science"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2012.00271\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2012.00271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2012.00271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T05:05:29Z","timestamp":1554527129000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2012.00271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,29]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["18091261"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2012.00271","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,29]]}}}